Intuitive Surgical (NASDAQ:ISRG) EVP Sells $169,656.00 in Stock

Intuitive Surgical, Inc. (NASDAQ:ISRG) EVP Gary Loeb sold 400 shares of the business’s stock in a transaction dated Wednesday, June 10th. The shares were sold at an average price of $424.14, for a total value of $169,656.00. Following the completion of the sale, the executive vice president directly owned 5,720 shares of the company’s stock, valued at approximately $2,426,080.80. This represents a 6.54% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Gary Loeb also recently made the following trade(s):

• On Monday, May 11th, Gary Loeb sold 400 shares of Intuitive Surgical stock. The shares were sold at an average price of $446.95, for a total value of $178,780.00.

Intuitive Surgical Stock Down 0.4%

Shares of Intuitive Surgical stock opened at $411.06 on Friday. The firm has a market cap of $145.58 billion, a P/E ratio of 49.83, a P/E/G ratio of 3.30 and a beta of 1.46. Intuitive Surgical, Inc. has a fifty-two week low of $396.68 and a fifty-two week high of $603.88. The business has a 50-day moving average price of $442.88 and a 200 day moving average price of $496.19.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings data on Tuesday, April 21st. The medical equipment provider reported $2.50 earnings per share for the quarter, beating the consensus estimate of $2.08 by $0.42. The firm had revenue of $2.77 billion during the quarter, compared to analyst estimates of $2.62 billion. Intuitive Surgical had a return on equity of 15.98% and a net margin of 28.15%.Intuitive Surgical’s quarterly revenue was up 23.0% on a year-over-year basis. During the same period in the previous year, the company earned $1.81 earnings per share. As a group, equities research analysts anticipate that Intuitive Surgical, Inc. will post 8.57 earnings per share for the current year.

Intuitive Surgical News Summary

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Analyst coverage remains broadly constructive, with brokerage sentiment still at a “Moderate Buy” and recent EPS estimate increases signaling confidence in Intuitive Surgical’s growth outlook.
• Positive Sentiment: Recent commentary highlights that the company’s scale, cost discipline, and adoption of the da Vinci 5 platform could help protect margins even if tariffs and input costs remain a concern.
• Neutral Sentiment: Investor attention has increased around ISRG, which can support trading activity, but this appears more like watchlist interest than a fresh business catalyst.
• Neutral Sentiment: BofA trimmed its price target slightly to $515 from $520, which still implies upside but signals a bit less optimism than before. Article: BofA adjusts price target on Intuitive Surgical to $515 from $520
• Neutral Sentiment: Two executives sold shares under pre-arranged 10b5-1 plans, including EVP Gary Loeb and EVP Mark Brosius. The sales were relatively small and routine, so they are unlikely to be a major fundamental concern.
• Negative Sentiment: One recent research note was notably bearish, with Deutsche Bank cutting its target to $366 and maintaining a sell rating, reinforcing concerns that valuation may still be too rich despite the company’s strong operating performance.
• Negative Sentiment: Seeking Alpha published a view calling Intuitive Surgical an “excellent business, unattractive stock,” reflecting ongoing investor caution around the valuation. Article: Intuitive Surgical: Excellent Business, Unattractive Stock

Wall Street Analysts Forecast Growth

Several analysts recently weighed in on the company. Jefferies Financial Group lowered their price objective on Intuitive Surgical from $560.00 to $515.00 and set a “hold” rating for the company in a report on Wednesday, April 22nd. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Intuitive Surgical in a report on Tuesday, May 19th. UBS Group lowered their target price on Intuitive Surgical from $570.00 to $550.00 and set a “neutral” rating for the company in a report on Tuesday, March 17th. Citigroup raised Intuitive Surgical from a “neutral” rating to a “buy” rating and set a $590.00 target price for the company in a report on Wednesday, March 11th. Finally, Raymond James Financial lowered their target price on Intuitive Surgical from $615.00 to $577.00 and set an “outperform” rating for the company in a report on Wednesday, April 22nd. Nineteen research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, Intuitive Surgical currently has an average rating of “Moderate Buy” and an average target price of $571.28.

Hedge Funds Weigh In On Intuitive Surgical

Several hedge funds and other institutional investors have recently made changes to their positions in the business. Defilade Capital Management L.P. boosted its position in shares of Intuitive Surgical by 48.2% during the first quarter. Defilade Capital Management L.P. now owns 67,681 shares of the medical equipment provider’s stock worth $31,200,000 after buying an additional 22,019 shares during the period. FAS Wealth Partners Inc. boosted its position in shares of Intuitive Surgical by 1.0% during the first quarter. FAS Wealth Partners Inc. now owns 5,282 shares of the medical equipment provider’s stock worth $2,435,000 after buying an additional 52 shares during the period. Pine Valley Investments Ltd Liability Co boosted its position in shares of Intuitive Surgical by 30.0% during the first quarter. Pine Valley Investments Ltd Liability Co now owns 2,350 shares of the medical equipment provider’s stock worth $1,083,000 after buying an additional 543 shares during the period. Evansbrook LLC boosted its position in shares of Intuitive Surgical by 5.4% during the first quarter. Evansbrook LLC now owns 1,651 shares of the medical equipment provider’s stock worth $761,000 after buying an additional 85 shares during the period. Finally, Parallel Advisors LLC boosted its position in shares of Intuitive Surgical by 0.8% during the first quarter. Parallel Advisors LLC now owns 40,733 shares of the medical equipment provider’s stock worth $18,778,000 after buying an additional 321 shares during the period. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Intuitive Surgical Company Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.